Replies to post #659880 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

There is no 150 day expedited approval program in the UK other than ILAP. I don't think it has any other meaning. But I don't know that they are seeking any other assistance at this time, so I doubt they will promote anything but whether they were approved for expedited review and the application was accepted. ILAP can be applied for early on in a trial, but the program was only announced in recent years, after NWBO had already finished the Phase 3. They seem not to be talking about special programs and that may simply be caution. Any such chatter in the past has been used to suggest negativity. But they clearly fit within the expectations of the program. The program was introduced to expedite drugs exactly like and in the position of DCVax-L to patients in the UK. That the drug was far along and had already completed its trials should not prevent them from applying to be considered for expedited approval. They seem reticent to talk about such programs after their past experiences.

[ilovetech]

DcVax has been slow walked for one reason or another for nearly 20 years. I can't think of a more appropriate consideration for a speedier effort by the regulator.

[biosectinvestor]

In addition to my other point, for the subsequent approvals for other cancers and other applications and maybe also for the PIP program, I expect that ILAP would be a perfect fit for them to get involved with from the very start.